Matches in Nanopublications for { ?s ?p "[Here we describe a rare case of APL relapsing as secondary AML with t(3;21)(q26;q22) and clinically characterize this patient using the RUNX1 (previously AML1)-MDS1-EVI1 fusion transcript (with follow-up for 55 months), and review the relevant literature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP566449.RAVUuaV8JxSX9U3LPcPgoTslphybAsz0lx60HqdGAdcFY130_assertion description "[Here we describe a rare case of APL relapsing as secondary AML with t(3;21)(q26;q22) and clinically characterize this patient using the RUNX1 (previously AML1)-MDS1-EVI1 fusion transcript (with follow-up for 55 months), and review the relevant literature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566449.RAVUuaV8JxSX9U3LPcPgoTslphybAsz0lx60HqdGAdcFY130_provenance.
- NP678017.RABt_F3SnjeiDmQkW8ZGXmaxii5W7xnoDKb7mkkP-szQo130_assertion description "[Here we describe a rare case of APL relapsing as secondary AML with t(3;21)(q26;q22) and clinically characterize this patient using the RUNX1 (previously AML1)-MDS1-EVI1 fusion transcript (with follow-up for 55 months), and review the relevant literature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678017.RABt_F3SnjeiDmQkW8ZGXmaxii5W7xnoDKb7mkkP-szQo130_provenance.
- NP317265.RAL206X63dDNhhWNxDA-PtUk8DYOSrmEXpnmBHsSxmW3U130_assertion description "[Here we describe a rare case of APL relapsing as secondary AML with t(3;21)(q26;q22) and clinically characterize this patient using the RUNX1 (previously AML1)-MDS1-EVI1 fusion transcript (with follow-up for 55 months), and review the relevant literature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317265.RAL206X63dDNhhWNxDA-PtUk8DYOSrmEXpnmBHsSxmW3U130_provenance.
- NP257107.RAHkWNyoVR5Ckw_JVAu3aEZRwgLK-vHDX2SpdzCMHOWmI130_assertion description "[Here we describe a rare case of APL relapsing as secondary AML with t(3;21)(q26;q22) and clinically characterize this patient using the RUNX1 (previously AML1)-MDS1-EVI1 fusion transcript (with follow-up for 55 months), and review the relevant literature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP257107.RAHkWNyoVR5Ckw_JVAu3aEZRwgLK-vHDX2SpdzCMHOWmI130_provenance.